Abbott Laboratories v. Gardner, 387 U.S. 136 (1967), was a case heard before the United States Supreme Court. The Court held that drug companies were not prohibited by the ripeness doctrine from challenging a U.S. Food and Drug Administration (FDA) regulation requiring a prescription drug's generic name to appear on all related printed materials.
Abbott Laboratories v. Gardner, 387 U.S. 136 (1967), was a case in which the United States Supreme Court deliberated. The Court issued a decision stating that pharmaceutical companies were not prohibited by the ripeness doctrine from disputing an FDA regulation requiring a prescription drug's generic name to appear on all related printed materials.